Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy
Keywords: Cyclic nucleotides; Multi-drug resistance protein; MK 571; BAY 60-2770; Platelet aggregation;